Comments

Entrada Therapeutics Insider Trading Activity

TRDANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$11.31

0.292.58%

Last update: Dec 16, 3:29 PM

Overview News Earnings Options Analyst Ratings

Insider Trades

Short Interest Stock Report

Entrada Therapeutics Insider Trading Activity | NASDAQ:TRDA | Benzinga

Track the latest Entrada Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Entrada Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Entrada Therapeutics Inc Insiders Doing?

At Entrada Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 408.91K shares worth $3.61M, meanwhile, insiders have reported buying a total of 28.87K shares for a total value of $261.85K.

Notable Recent Insider Buys and Sales

On November 12, 2025, BAKER BROS ADVISORS LP, Baker Bros Advisors GP LLC, FELIX BAKER, JULIAN BAKER, the company's - purchased 178.04K shares for $7.6 each.
On November 24, 2025, BAKER BROS ADVISORS LP, Baker Bros Advisors GP LLC, FELIX BAKER, JULIAN BAKER, the company's - purchased 28.87K shares for $9.07 each.
On November 24, 2025, JAMES KORY WENTWORTH, the company's CHIEF FINANCIAL OFFICER sold 8.91K shares for $9.98 each.

Ownership Statistics for Entrada Therapeutics Inc

Shares Outstanding

38.219M

Insider Shares Owned

1.065M

Insider Percentage Owned

2.79%

Institutional Shares Held

6.111M

Institutional Percentage Held

16.0%


Nov 24, 2025	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-8.91K	$9.98	-$88.93K	SELL	-7.49%	110.03K	Nov 21	View
Nov 24, 2025	BAKER BROS ADVISORS LP Baker Bros Advisors GP LLC FELIX BAKER JULIAN BAKER	—	28.87K	$9.07	$261.85K	BUY	0.62%	4.69M	Nov 20	View
Nov 18, 2025	Kush Parmar	—	-200.00K	$8.80	-$1.76M	SELL	-4.70%	4.06M	Nov 14	View
Nov 18, 2025	AM Ventures V LP AM Partners V LLC AM Opportunities I LP AM Opportunities I GP LLC SCOTT ROCKLAGE Andrew Schwab	10% OWNER	-200.00K	$8.80	-$1.76M	SELL	-4.70%	4.06M	Nov 14	View
Nov 12, 2025	BAKER BROS ADVISORS LP Baker Bros Advisors GP LLC FELIX BAKER JULIAN BAKER	—	178.04K	$7.60	$1.35M	BUY	3.97%	4.66M	Nov 10 - Nov 12	View
Jul 11, 2025	Kush Parmar	—	-27.00K	$7.50	-$202.55K	SELL	-2.41%	1.09M	Jul 09	View
Jul 11, 2025	AM Ventures V LP AM Partners V LLC AM Opportunities I LP AM Opportunities I GP LLC SCOTT ROCKLAGE Andrew Schwab	10% OWNER	-27.00K	$7.50	-$202.55K	SELL	-2.41%	1.09M	Jul 09	View
Jul 01, 2025	Kush Parmar	—	-125.00K	$6.93	-$866.63K	SELL	-10.20%	1.10M	Jun 27 - Jul 01	View
Jul 01, 2025	AM Ventures V LP AM Partners V LLC AM Opportunities I LP AM Opportunities I GP LLC SCOTT ROCKLAGE Andrew Schwab	10% OWNER	-125.00K	$6.93	-$866.63K	SELL	-10.20%	1.10M	Jun 27 - Jul 01	View
Mar 19, 2025	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-1.78K	$10.67	-$19.04K	SELL	-1.60%	109.54K	Mar 17	View
Dec 12, 2024	MPM BIOVENTURES LP MPM BioVentures LLC MPM BioVentures GP LLC	10% OWNER	-44.72K	$20.51	-$917.11K	SELL	-1.01%	4.38M	Dec 10 - Dec 11	View
Dec 12, 2024	MPM BioVentures LP LUKE EVNIN ANSBERT GADICKE Todd Foley MPM BioVentures B LP MPM Asset Management Investors BV LLC MPM BioVentures LLC MPM BioVentures GP LLC MPM BIOVENTURES B LP MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	-44.72K	$20.51	-$917.11K	SELL	-1.01%	4.38M	Dec 10 - Dec 11	View
Dec 03, 2024	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$11.05	-$107.35K	SELL-OPTIONS	0.00%	73.85K	Nov 29 - Dec 02	View
Dec 03, 2024	Natarajan Sethuraman	PRESIDENT, RESEARCH & DEVELOP.	-15.89K	$20.18	-$320.62K	SELL	-9.88%	145.00K	Nov 29 - Dec 03	View
Nov 13, 2024	Natarajan Sethuraman	PRESIDENT, RESEARCH & DEVELOP.	-4.11K	$20.03	-$82.30K	SELL	-2.49%	160.89K	Nov 11 - Nov 13	View
Nov 13, 2024	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-2.64K	$11.04	-$159.96K	SELL	-3.45%	73.85K	Nov 11	View
Nov 06, 2024	Natarajan Sethuraman	PRESIDENT, RESEARCH & DEVELOP.	-18.22K	$18.62	-$339.28K	SELL	-9.94%	165.00K	Nov 04 - Nov 06	View
Oct 18, 2024	Natarajan Sethuraman	PRESIDENT, RESEARCH & DEVELOP.	-600.00	$18.00	-$10.80K	SELL	-0.33%	183.22K	Oct 16	View
Sep 30, 2024	Nathan Dowden	PRESIDENT & COO	-847.00	$16.00	-$13.55K	SELL	-0.67%	125.15K	Sep 26	View
Sep 10, 2024	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-3.19K	$14.97	-$47.83K	SELL	-4.01%	76.49K	Sep 09	View
Sep 10, 2024	Nathan Dowden	PRESIDENT & COO	-2.30K	$15.09	-$34.75K	SELL	-1.80%	126.00K	Sep 06 - Sep 09	View
Sep 10, 2024	Natarajan Sethuraman	CHIEF SCIENTIFIC OFFICER	-3.24K	$15.12	-$49.00K	SELL	-1.73%	183.82K	Sep 06 - Sep 09	View
Aug 20, 2024	Nathan Dowden	PRESIDENT & COO	-7.10K	$9.00	-$406.00K	SELL	-5.17%	130.11K	Aug 16	View
Jul 16, 2024	Natarajan Sethuraman	CHIEF SCIENTIFIC OFFICER	-1.24K	$18.00	-$22.28K	SELL	-0.65%	188.81K	Jul 12 - Jul 15	View
Jul 16, 2024	Dipal Doshi	CEO	-1.90K	$17.84	-$33.90K	SELL	-0.56%	334.48K	Jul 12 - Jul 15	View
Jul 10, 2024	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-1.76K	$14.95	-$26.28K	SELL	-2.11%	81.41K	Jul 08	View
Jun 14, 2024	Dipal Doshi	CEO	-1.00K	$16.17	-$16.17K	SELL	-0.30%	336.38K	Jun 13	View
May 20, 2024	Natarajan Sethuraman	CHIEF SCIENTIFIC OFFICER	-18.98K	$15.16	-$287.69K	SELL	-9.08%	190.05K	May 16 - May 20	View
May 20, 2024	Dipal Doshi	CEO	-3.00K	$15.04	-$45.13K	SELL	-0.88%	337.38K	May 16 - May 17	View
May 16, 2024	PETER KIM	DIRECTOR	25.00K	$14.59	$364.67K	BUY	37.09%	92.41K	May 14	View
May 10, 2024	PETER KIM	DIRECTOR	4.48K	$14.14	$63.31K	BUY	7.11%	67.41K	May 08 - May 09	View
Apr 10, 2024	PETER KIM	DIRECTOR	2.60K	$13.57	$35.29K	BUY	4.31%	62.94K	Apr 08	View
Apr 01, 2024	PETER KIM	DIRECTOR	1.51K	$13.75	$20.79K	BUY	2.57%	60.34K	Mar 28	View
Mar 26, 2024	PETER KIM	DIRECTOR	9.05K	$13.58	$122.88K	BUY	18.18%	58.82K	Mar 22 - Mar 26	View
Mar 21, 2024	PETER KIM	DIRECTOR	2.73K	$12.81	$35.00K	BUY	5.81%	49.78K	Mar 19 - Mar 21	View
Mar 08, 2024	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-4.09K	$12.31	-$50.29K	SELL	-5.22%	74.17K	Mar 06	View
Mar 08, 2024	Nathan Dowden	PRESIDENT & COO	-1.83K	$12.32	-$22.50K	SELL	-1.31%	137.20K	Mar 06	View
Feb 20, 2024	Dipal Doshi	CEO	-1.00K	$15.00	-$15.00K	SELL	-0.41%	243.28K	Feb 15	View
Jan 18, 2024	Dipal Doshi	CEO	-1.00K	$15.99	-$15.99K	SELL	-0.41%	244.28K	Jan 16	View
Dec 26, 2023	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$8.84	-$168.60K	SELL-OPTIONS	0.00%	49.57K	Dec 21 - Dec 26	View
Dec 22, 2023	Dipal Doshi	PRESIDENT AND CEO	-1.00K	$15.00	-$15.00K	SELL	-0.41%	245.28K	Dec 20	View
Nov 13, 2023	Dipal Doshi	PRESIDENT AND CEO	-1.00K	$16.23	-$16.23K	SELL	-0.40%	246.28K	Nov 13	View
Oct 19, 2023	Dipal Doshi	PRESIDENT AND CEO	-1.00K	$15.00	-$15.00K	SELL	-0.40%	247.28K	Oct 17	View
Sep 15, 2023	Dipal Doshi	PRESIDENT AND CEO	-1.00K	$15.00	-$15.00K	SELL	-0.40%	248.28K	Sep 13	View
Sep 06, 2023	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	12.82K	$13.78	-$18.97K	GRANT	34.90%	49.57K	Sep 01 - Sep 06	View
Sep 06, 2023	NERISSA KREHER	CHIEF MEDICAL OFFICER	12.91K	$13.78	-$17.82K	GRANT	47.57%	40.04K	Sep 01 - Sep 06	View
Sep 06, 2023	Nathan Dowden	CHIEF OPERATING OFFICER	12.79K	$13.77	-$19.39K	GRANT	36.16%	48.17K	Sep 01 - Sep 06	View
Aug 16, 2023	Dipal Doshi	PRESIDENT AND CEO	-1.00K	$15.67	-$15.67K	SELL	-0.49%	201.07K	Aug 14	View
Aug 04, 2023	NERISSA KREHER	CHIEF MEDICAL OFFICER	0.00	$8.43	-$338.13K	SELL-OPTIONS	0.00%	27.13K	Aug 02 - Aug 04	View
Jul 12, 2023	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$10.04	-$158.86K	SELL-OPTIONS	0.00%	36.75K	Jul 10 - Jul 11	View
Jul 12, 2023	Nathan Dowden	CHIEF OPERATING OFFICER	-7.10K	$18.03	-$127.94K	SELL	-16.71%	35.38K	Jul 10 - Jul 11	View
Jul 12, 2023	Natarajan Sethuraman	CHIEF SCIENTIFIC OFFICER	-17.88K	$18.03	-$322.39K	SELL	-10.44%	153.45K	Jul 10 - Jul 11	View
Jun 23, 2023	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$8.55	-$225.90K	SELL-OPTIONS	0.00%	27.96K	Jun 21	View
Jun 22, 2023	Nathan Dowden	CHIEF OPERATING OFFICER	-15.98K	$15.42	-$246.40K	SELL	-27.34%	42.47K	Jun 20 - Jun 22	View
May 01, 2023	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$13.71	-$27.42K	SELL	-0.98%	202.07K	Apr 27	View
Apr 19, 2023	Dipal Doshi	PRESIDENT AND CEO	-2.09K	$18.01	-$37.68K	SELL	-1.01%	204.07K	Apr 17	View
Apr 19, 2023	Natarajan Sethuraman	CHIEF SCIENTIFIC OFFICER	-3.96K	$18.00	-$71.32K	SELL	-2.26%	171.32K	Apr 17	View
Mar 29, 2023	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$14.72	-$29.44K	SELL	-0.78%	255.81K	Mar 27	View
Mar 03, 2023	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	25.65K	$10.92	-$30.04K	GRANT	155.36%	42.16K	Mar 01 - Mar 02	View
Mar 03, 2023	NERISSA KREHER	CHIEF MEDICAL OFFICER	25.81K	$10.94	-$28.29K	GRANT	166.37%	41.33K	Mar 01 - Mar 02	View
Mar 02, 2023	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$12.00	-$24.00K	SELL	-1.22%	161.84K	Feb 28	View
Jan 30, 2023	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$12.00	-$24.00K	SELL	-1.21%	163.84K	Jan 27	View
Jan 10, 2023	Dipal Doshi	PRESIDENT AND CEO	-2.41K	$15.02	-$36.20K	SELL	-1.43%	165.84K	Jan 09	View
Jan 03, 2023	NERISSA KREHER	CHIEF MEDICAL OFFICER	-5.20K	$13.45	-$69.93K	SELL	-25.10%	15.52K	Dec 30	View
Dec 29, 2022	Dipal Doshi	PRESIDENT AND CEO	-14.59K	$15.02	-$219.12K	SELL	-7.98%	168.25K	Dec 27 - Dec 29	View
Dec 12, 2022	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$10.53	-$76.68K	SELL-OPTIONS	0.00%	16.51K	Dec 08	View
Dec 06, 2022	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$10.14	-$50.03K	SELL-OPTIONS	0.00%	16.51K	Dec 02 - Dec 05	View
Nov 30, 2022	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$13.91	-$27.83K	SELL	-1.08%	182.84K	Nov 28	View
Nov 18, 2022	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	0.00	$10.10	-$3.20K	SELL-OPTIONS	0.00%	16.51K	Nov 16	View
Nov 02, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-2.10K	$24.05	-$50.50K	SELL	-4.43%	45.28K	Oct 31	View
Oct 27, 2022	NERISSA KREHER	CHIEF MEDICAL OFFICER	0.00	$11.69	-$249.25K	SELL-OPTIONS	0.00%	20.72K	Oct 25 - Oct 26	View
Oct 27, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-9.35K	$20.77	-$194.19K	SELL	-16.48%	47.38K	Oct 25	View
Oct 27, 2022	Dipal Doshi	PRESIDENT AND CEO	-14.06K	$20.80	-$292.51K	SELL	-7.07%	184.84K	Oct 25 - Oct 27	View
Oct 24, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-6.08K	$18.66	-$113.43K	SELL	-9.68%	56.73K	Oct 20 - Oct 24	View
Oct 24, 2022	Dipal Doshi	PRESIDENT AND CEO	-5.94K	$18.64	-$110.71K	SELL	-2.90%	198.90K	Oct 20 - Oct 24	View
Sep 28, 2022	Dipal Doshi	PRESIDENT AND CEO	-10.59K	$15.25	-$161.44K	SELL	-4.91%	204.84K	Sep 26 - Sep 28	View
Sep 28, 2022	NERISSA KREHER	CHIEF MEDICAL OFFICER	0.00	$8.70	-$113.38K	SELL-OPTIONS	0.00%	20.72K	Sep 26 - Sep 28	View
Sep 28, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-1.54K	$15.45	-$23.85K	SELL	-2.40%	62.81K	Sep 26	View
Sep 23, 2022	Dipal Doshi	PRESIDENT AND CEO	-4.42K	$15.10	-$66.84K	SELL	-2.01%	215.42K	Sep 21 - Sep 23	View
Sep 23, 2022	NERISSA KREHER	CHIEF MEDICAL OFFICER	0.00	$8.59	-$55.57K	SELL-OPTIONS	0.00%	20.72K	Sep 21 - Sep 23	View
Sep 23, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-4.29K	$15.11	-$64.88K	SELL	-6.25%	64.36K	Sep 21 - Sep 23	View
Sep 19, 2022	Dipal Doshi	PRESIDENT AND CEO	-200.00	$15.04	-$3.01K	SELL	-0.09%	219.85K	Sep 15	View
Sep 19, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-100.00	$15.01	-$1.50K	SELL	-0.15%	68.65K	Sep 15	View
Sep 19, 2022	NERISSA KREHER	CHIEF MEDICAL OFFICER	0.00	$8.56	-$1.37K	SELL-OPTIONS	0.00%	20.72K	Sep 15	View
Sep 12, 2022	Dipal Doshi	PRESIDENT AND CEO	-1.79K	$15.12	-$27.04K	SELL	-0.81%	220.05K	Sep 08 - Sep 09	View
Sep 12, 2022	NERISSA KREHER	CHIEF MEDICAL OFFICER	0.00	$8.60	-$26.29K	SELL-OPTIONS	0.00%	20.72K	Sep 08 - Sep 09	View
Sep 12, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-1.78K	$15.11	-$26.85K	SELL	-2.52%	68.75K	Sep 08 - Sep 09	View
Aug 31, 2022	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$12.72	-$25.44K	SELL	-0.96%	206.71K	Aug 29 - Aug 31	View
Aug 26, 2022	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-3.55K	$7.94	-$62.02K	SELL	-24.43%	10.99K	Aug 24 - Aug 25	View
Aug 23, 2022	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-5.68K	$7.59	-$139.89K	SELL	-28.10%	14.54K	Aug 19 - Aug 23	View
Aug 18, 2022	JAMES KORY WENTWORTH	CHIEF FINANCIAL OFFICER	-300.00	$7.56	-$7.18K	SELL	-1.46%	20.22K	Aug 16 - Aug 18	View
Jul 29, 2022	Dipal Doshi	PRESIDENT AND CEO	-2.00K	$12.00	-$24.00K	SELL	-0.95%	208.71K	Jul 27	View
Jun 29, 2022	Nathan Dowden	CHIEF OPERATING OFFICER	-7.71K	$13.00	-$100.28K	SELL	-10.62%	64.89K	Jun 27	View
Jun 29, 2022	Dipal Doshi	PRESIDENT AND CEO	-4.00K	$12.00	-$48.00K	SELL	-1.86%	210.71K	Jun 27	View
Jun 06, 2022	BAKER BROS ADVISORS LP JULIAN BAKER FELIX BAKER Baker Bros Advisors GP LLC	10% OWNER	40.95K	$6.37	$260.76K	BUY	0.92%	4.50M	Jun 02 - Jun 06	View
May 24, 2022	BAKER BROS ADVISORS LP JULIAN BAKER FELIX BAKER Baker Bros Advisors GP LLC	10% OWNER	48.51K	$5.82	$282.45K	BUY	1.10%	4.47M	May 20 - May 24	View
May 18, 2022	BAKER BROS ADVISORS LP JULIAN BAKER FELIX BAKER Baker Bros Advisors GP LLC	10% OWNER	71.94K	$5.99	$430.70K	BUY	1.65%	4.42M	May 16 - May 18	View
Jan 13, 2022	John Crowley	DIRECTOR	5.00K	$9.71	$48.58K	BUY	15.21%	37.86K	Jan 12	View
Nov 05, 2021	KUSH PARMAR	DIRECTOR	4.08M	$20.00	$5.00M	BUY	∞	1.13M	Nov 02	View
Nov 04, 2021	AM Ventures V LP AM Partners V LLC AM Opportunities I LP AM Opportunities I GP LLC SCOTT ROCKLAGE Andrew Schwab	10% OWNER	4.08M	$20.00	$5.00M	BUY	∞	1.13M	Nov 02	View
Nov 04, 2021	Redmile Group LLC Jeremy Green Redmile Biopharma Investments III LP	10% OWNER	1.95M	$20.00	$20.00M	BUY	∞	1.95M	Nov 02	View
Nov 04, 2021	MPM BIOVENTURES LP MPM BioVentures LLC MPM BioVentures GP LLC	10% OWNER	4.43M	$20.00	$2.00M	BUY	∞	4.43M	Nov 02	View
Nov 04, 2021	MPM BioVentures LP LUKE EVNIN ANSBERT GADICKE MPM BioVentures B LP MPM Asset Management Investors BV LLC MPM BioVentures LLC MPM BioVentures GP LLC MPM BIOVENTURES B LP MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	4.43M	$20.00	$2.00M	BUY	∞	4.43M	Nov 02	View
Nov 04, 2021	Todd Foley	DIRECTOR	4.43M	$20.00	$2.00M	BUY	∞	4.43M	Nov 02	View

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.